Opioid-based micro and nanoparticulate formulations: alternative approach on pain management

References

• Aamir MN, Ahmad M. Development of tramadol microparticles by non-solvent addition method and their in vitro characterization. Iran Polym J, 2009;18:937–46.
   Web of Science ®Google Scholar
• Aamir MN, Ahmad M, Akhtar N, Murtaza G, Khan SA, Nokhodchi A. Development and in vitro–in vivo relationship of controlled-release microparticles loaded with tramadol hydrochloride. Int J Pharm, 2011;40:7 38–43.
   Web of Science ®Google Scholar
• Adams E, Chwiecko P, Guary J, Ghalie R, De Jong E. (825): Pain control in chronic non-cancer pain patients treated with once-a-day AVINZA (morphine sulfate extended-release capsules). J Pain, 2006;7:S57.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev, 2013;65:36–48.
   PubMed Web of Science ®Google Scholar
• Allouche S, Noble F, Marie N. Opioid receptor desensitization: mechanisms and its link to tolerance. Front Pharmacol, 2014;5:1–20.
   PubMed Web of Science ®Google Scholar
• Alyautdin RN, Petrov VE, Langer K, Berthold A, Kharkevich DA, Kreuter J. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm Res, 1997;14:325–8.
   PubMed Web of Science ®Google Scholar
• Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 2012;64:72–82.
   Web of Science ®Google Scholar
• AP. 2010. Product Document Kadian. Bristol, TN: Alpharma Pharmaceuticals, Inc.
   Google Scholar
• Arias JL, Gomez-Gallo A, Delgado AV, Ruiz MA, Kollidon SR. Colloidal particles as vehicles for oral morphine delivery in pain treatment. Colloids Surf B Biointerfaces, 2009;70:207–12.
   PubMed Web of Science ®Google Scholar
• Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: A review of the evidence. Clin J Pain, 2008;24:469–78.
   PubMed Web of Science ®Google Scholar
• Bernards CM, Luger TJ, Malmberg AB, Hill HF, Yaksh TL. Liposome encapsulation prolongs alfentanil spinal analgesia and alters systemic redistribution in the rat. Anesthesiology, 1992;77:529–35.
   PubMed Web of Science ®Google Scholar
• Bethune CR, Bernards CM, Bui-Nguyen T, Shen DD, Ho RJ. The role of drug-lipid interactions on the disposition of liposome-formulated opioid analgesics in vitro and in vivo. Anesth Analg, 2001;93:928–33.
   PubMed Web of Science ®Google Scholar
• Bourland J. 2011. Opiates history and chemical structures. Drug Testing Matters. Washington, DC: National Laboratory Certified Program.
   Google Scholar
• Breasted JH. 2001. Ancient records of Egypt – The nineteenth dinasty. Champaign (IL): University of Illinois Press.
   Google Scholar
• Budai M, Szabó Z, Szögyi M, Gróf P. Molecular interactions between DPPC and morphine derivatives: A DSC and EPR study. Int J Pharm, 2003;250:239–50.
   PubMed Web of Science ®Google Scholar
• Buttini F, Colombo P, Rossi A, Sonvico F, Colombo G. Particles and powders: Tools of innovation for non-invasive drug administration. J Control Release, 2012;161:693–702.
   PubMed Web of Science ®Google Scholar
• Caldwell JR. Avinza – 24-h sustained-release oral morphine therapy. Expert Opin Pharmacother, 2004;5:469–72.
   PubMed Web of Science ®Google Scholar
• Campbell SB, Hoare T. Externally addressable hydrogel nanocomposites for biomedical applications. Curr Opin Chem Eng, 2014;4:1–10.
   Web of Science ®Google Scholar
• Chakravarthi SS, De S, Miller DW, Robinson DH. Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticles. Int J Pharm, 2010;383:37–44.
   PubMed Web of Science ®Google Scholar
• Chang HC, Li LC. Sustained-release butorphanol microparticles. Drug Dev Ind Pharm, 2000;26:829–35.
   PubMed Web of Science ®Google Scholar
• Chen F, Yin G, Liao X, Yang Y, Huang Z, Gu J, Yao Y, Chen X, Gao H. Preparation, characterization and in vitro release properties of morphine-loaded PLLA-PEG-PLLA microparticles via solution enhanced dispersion by supercritical fluids. J Mater Sci Mater Med, 2013a;24:1693–705.
   PubMed Web of Science ®Google Scholar
• Chen Y-C, Hsieh W-Y, Lee W-F, Zeng D-T. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier. J Biomater Appl, 2013b;27:909–22.
   PubMed Web of Science ®Google Scholar
• Da Silva E, Bresson S, Rousseau D. Characterization of the three major polymorphic forms and liquid state of tristearin by Raman spectroscopy. Chem Phys Lipids, 2009;157:113–19.
   PubMed Web of Science ®Google Scholar
• Dalwadi G, Sunderland B. Comparison and validation of drug loading parameters of PEGylated nanoparticles purified by a diafiltration centrifugal device and tangential flow filtration. Drug Dev Ind Pharm, 2008;34:1331–42.
   PubMed Web of Science ®Google Scholar
• David G, Jaba IM, Tamba B, Bohotin C, Neamtu A. Antinociceptive effect of morphiceptin loaded poly(butyl cyanoacrylate) nanoparticles. Rev Roum Chim, 2010;55:923–31.
   Web of Science ®Google Scholar
• Dinarvand R, Moghadam SH, Sheikhi A, Atyabi F. Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique. J Microencapsul, 2005;22:139–51.
   PubMed Web of Science ®Google Scholar
• Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: A systematic review and meta-analysis of health utilities. Pain, 2010;149:338–44.
   PubMed Web of Science ®Google Scholar
• Dumas EO, Pollack GM. Opioid tolerance development: A pharmacokinetic/pharmacodynamic perspective. AAPS J, 2008;10:537–51.
   PubMed Web of Science ®Google Scholar
• Eskandari S, Varamini P, Toth I. Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery. J Liposome Res, 2013;23:311–7.
   PubMed Web of Science ®Google Scholar
• Fang JY, Wu PC, Fang CL, Chen CH. Intravesical delivery of 5-aminolevulinic acid from water-in-oil nano/submicron-emulsion systems. J Pharm Sci, 2010;99:2375–85.
   PubMed Web of Science ®Google Scholar
• Fernandez-Arevalo M, Alvarez-Fuentes J, Iruin A, Holgado MA. In vitro evaluation of a morphine polymeric complex: Flowability behavior and dissolution study. AAPS PharmSciTech, 2004;5:e39.
   PubMedGoogle Scholar
• Fielding R, Wong W. Prevalence of chronic pain, insomnia, and fatigue in Hong Kong. Hong Kong Med J, 2012;18:S9–12.
   PubMedGoogle Scholar
• Fraser SA, Ting YH, Mallon KS, Wendt AE, Murphy CJ, Nealey PF. Sub-micron and nanoscale feature depth modulates alignment of stromal fibroblasts and corneal epithelial cells in serum-rich and serum-free media. J Biomed Mater Res A, 2008;86:725–35.
   PubMed Web of Science ®Google Scholar
• Fröhlich E, Roblegg E. Models for oral uptake of nanoparticles in consumer products. Toxicology, 2012;291:10–7.
   PubMed Web of Science ®Google Scholar
• Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med, 2005;172:1487–90.
   PubMed Web of Science ®Google Scholar
• Gambling D, Hughes T, Martin G, Horton W, Manvelian G. A comparison of Depodur, a novel, single-dose extended-release epidural morphine, with standard epidural morphine for pain relief after lower abdominal surgery. Anesth Analg, 2005;100:1065–74.
   PubMed Web of Science ®Google Scholar
• Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain, 2012;13:715–24.
   PubMed Web of Science ®Google Scholar
• Grabrucker A, Chhabra R, Belletti D, Forni F, Vandelli M, Ruozi B, Tosi G. 2013, Nanoparticles as blood–brain barrier permeable CNS targeted drug delivery systems. In: Topics in medicinal chemistry. Berlin/Heidelberg: Springer; pp. 1–19.
   Google Scholar
• Grant GJ, Vermeulen K, Zakowski MI, Stenner M, Turndorf H, Langerman L. Prolonged analgesia and decreased toxicity with liposomal morphine in a mouse model. Anesth Analg, 1994;79:706–9.
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. 2007. Encapsulation of drugs within liposomes by pH-gradient techniques. In: Liposome technology – Entrapment of drugs and other materials into liposomes, 3rd ed. New York: Informa Healthcare, pp. 27–45.
   Google Scholar
• Groenendaal D, Blom-Roosemalen MCM, Danhof M, Lange ECMd. High-performance liquid chromatography of nalbuphine, butorphanol and morphine in blood and brain microdialysate samples: Application to pharmacokinetic/pharmacodynamic studies in rats. J Chromatogr B Analyt Technol Biomed Life Sci, 2005;822:230–7.
   PubMed Web of Science ®Google Scholar
• Hardy CL, Lemasurier JS, Mohamud R, Yao J, Xiang SD, Rolland JM, O’Hehir RE, Plebanski M. Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints. J Immunol, 2013;191:5278–90.
   PubMed Web of Science ®Google Scholar
• Harris R, Lecumberri E, Heras A. Chitosan-genipin microspheres for the controlled release of drugs: Clarithromycin, tramadol and heparin. Mar Drugs, 2010;8:1750–62.
   PubMed Web of Science ®Google Scholar
• Häuser W, Schmutzer G, Hinz A, Hilbert A, Brähler E. Prävalenz chronischer Schmerzen in Deutschland. Der Schmerz, 2013;27:46–55.
   PubMed Web of Science ®Google Scholar
• He S, Zhu J, Xie F. Preparation and characterization of tramadol PEG-coated multivesicular liposomes for sustained release. Pharmazie, 2010;65:467–70.
   PubMed Web of Science ®Google Scholar
• Van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its clinical relevance. Br J Anaesth, 2013;111:13–18.
   PubMed Web of Science ®Google Scholar
• Hekmatara T, Gelperina S, Vogel V, Yang SR, Kreuter J. Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles. J Nanosci Nanotechnol, 2009;9:5091–8.
   PubMed Web of Science ®Google Scholar
• Hoekman JD, Srivastava P, Ho RJY. Aerosol-stable peptide-coated liposome nanoparticles: A proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure. J Pharm Sci, 2014;103:2231–9.
   PubMed Web of Science ®Google Scholar
• Holt D, Viscusi E, Wordell C. Extended-duration agents for perioperative pain management. Curr Pain Headache Rep, 2007;11:33–7.
   PubMedGoogle Scholar
• Huber DL. Synthesis, properties, and applications of iron nanoparticles. Small, 2005;1:482–501.
   PubMed Web of Science ®Google Scholar
• Hung OR, Whynot SC, Varvel JR, Shafer SL, Mezei M. Pharmacokinetics of inhaled liposome-encapsulated fentanyl. Anesthesiology, 1995;83:277–84.
   PubMed Web of Science ®Google Scholar
• Ji TF, Cao HM, Liang JJ, Wu Q, Miao PL. Effects of intrathecal solid lipid nanoparticles morphine on acute nociception in rats. Chin J Pathophysiol, 2008;24:1993–6.
   Google Scholar
• Jitsu K. Drug information for pain control. KADIAN (morphine sulfate sustained release). Pain Clin, 2000;21:1029–32.
   Google Scholar
• Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: Results of an internet-based survey. J Pain, 2010;11:1230–9.
   PubMed Web of Science ®Google Scholar
• Joseph E, Saha RN. Advances in brain targeted drug delivery: Nanoparticulate systems. PharmaSciTech, 2013;3:1–8.
   Google Scholar
• Joshi MD, Muller RH. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm, 2009;71:161–72.
   PubMed Web of Science ®Google Scholar
• Kamble VA, Jagdale DM, Kadam VJ. Solid lipid nanoparticles as drug delivery system. Int J Pharma Bio Sci, 2010;1:1–9.
   Google Scholar
• Knych HK, Casbeer HC, Mckemie DS, Arthur RM. Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse. J Vet Pharmacol Ther, 2013;36:21–30.
   PubMed Web of Science ®Google Scholar
• Kohane DS. Microparticles and nanoparticles for drug delivery. Biotechnol Bioeng, 2007;96:203–9.
   PubMed Web of Science ®Google Scholar
• KP. 2008 Product Document Avinza. Bristol, TN: King Pharmaceuticals, Inc.
   Google Scholar
• Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target, 2002;10:317–25.
   PubMed Web of Science ®Google Scholar
• Krugner-Higby L, KuKanich B, Schmidt B, Heath TD, Brown C, Smith LJ. Pharmacokinetics and behavioral effects of an extended-release, liposome-encapsulated preparation of oxymorphone in rhesus macaques. J Pharmacol Exp Ther, 2009;330:135–41.
   PubMed Web of Science ®Google Scholar
• Küchler S, Wolf NB, Heilmann S, Weindl G, Helfmann J, Yahya MM, Stein C, Schafer-Korting M. 3D-wound healing model: Influence of morphine and solid lipid nanoparticles. J Biotechnol, 2010;148:24–30.
   PubMed Web of Science ®Google Scholar
• Lasic DD. 1993. Chemistry of Lipids and Liposomes. In: Liposomes, from physics to application. Amsterdam: Elsevier, pp. 9–40.
   Google Scholar
• Lehner R, Wang X, Marsch S, Hunziker P. Intelligent nanomaterials for medicine: Carrier platforms and targeting strategies in the context of clinical application. Nanomedicine, 2013;9:742–57.
   PubMed Web of Science ®Google Scholar
• Lim GJ, Ishiuji Y, Dawn A, Harrison B, Kim do W, Atala A, Yosipovitch G. In vitro and in vivo characterization of a novel liposomal butorphanol formulation for treatment of pruritus. Acta Derm Venereol, 2008;88:327–30.
   PubMed Web of Science ®Google Scholar
• Maderuelo C, Zarzuelo A, Lanao JM. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Release, 2011;154:2–19.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Benyamin R, Datta S, Vallejo R, Smith H. Opioids in chronic noncancer pain. Expert Rev Neurother, 2010;10:775–89.
   PubMed Web of Science ®Google Scholar
• Mantripragada S. 2003. DepoFoam technology. In: Rathbone, MJ, Hadgraft, J, Roberts, MS, eds. Modified-release drug delivery technology. New York: Marcel Dekker, Inc., pp. 705–12.
   Google Scholar
• Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal carriers for peptide and protein delivery - liposomes versus lipid nanoparticles. Int J Nanomedicine, 2007;2:595–607.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 2001;47:165–96.
   PubMed Web of Science ®Google Scholar
• Merskey H, Bogduk N. 1994. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP Press.
   Google Scholar
• Mohanraj V, Chen Y. Nanoparticles – A review. Trop J Pharm Res, 2006;5:561–73.
   Google Scholar
• Morales ME, Gallardo Lara V, Calpena AC, Domenech J, Ruiz MA. Comparative study of morphine diffusion from sustained release polymeric suspensions. J Control Release, 2004;95:75–81.
   PubMed Web of Science ®Google Scholar
• Morales ME, Ruiz MA, López G, Gallardo V. Development of oral suspensions of microparticles of ethylcellulose with tramadol. Drug Dev Ind Pharm, 2010;36:885–92.
   PubMed Web of Science ®Google Scholar
• Morales ME, Ruiz MA, Oliva I, Oliva M, Gallardo V. Chemical characterization with XPS of the surface of polymer microparticles loaded with morphine. Int J Pharm, 2007;333:162–6.
   PubMed Web of Science ®Google Scholar
• Mozafari MR. Liposomes: An overview of manufacturing techniques. Cell Mol Biol Lett, 2005;10:711–9.
   PubMed Web of Science ®Google Scholar
• Müller RH. 1991. Colloidal carriers for controlled drug delivery and targeting-modification, characterization and in vivo distribution. 1st ed. Boca Raton: Wissenschaftliche Verlagsgesellschaft Stuttgart/CRC Press.
   Google Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev, 2002;54 Suppl 1:S131–55.
   Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – A review of the state of the art. Eur J Pharm Biopharm, 2000;50:161–77.
   PubMed Web of Science ®Google Scholar
• Nagle PC, Gerancher JC. DepoDur® (extended-release epidural morphine): A review of an old drug in a new vehicle. Tech Reg Anesth Pain Manag, 2007;11:9–18.
   Google Scholar
• New RRC. 1990. Introduction. In: Liposomes: A practical approach. New York: Oxford University Press, pp. 1–31.
   Google Scholar
• Ngwuluka NC, Choonara YE, Modi G, du Toit LC, Kumar P, Ndesendo VMK, Pillay V. Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease. AAPS PharmSciTech, 2013;14:605–19.
   PubMed Web of Science ®Google Scholar
• Olivier J-C. Drug transport to brain with targeted nanoparticles. NeuroRx, 2005;2:108–19.
   PubMedGoogle Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm, 2009;366:170–84.
   PubMed Web of Science ®Google Scholar
• Pasero C, McCaffery M. Extended-release epidural morphine (DepoDur). J Perianesth Nurs, 2005;20:345–50.
   PubMedGoogle Scholar
• Patel AS, Soni TG, Thakkar VT, Gandhi TR. Effect of polymeric blend on the dissolution behavior of spray-dried microparticles. Int J Res Pharm Chem, 2011;1:690–701.
   Web of Science ®Google Scholar
• Pietkiewicz J, Sznitowska M, Placzek M. The expulsion of lipophilic drugs from the cores of solid lipid microspheres in diluted suspensions and in concentrates. Int J Pharm, 2006;310:64–71.
   PubMed Web of Science ®Google Scholar
• Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F, Reis PC. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine, 2006;2:8–21.
   PubMed Web of Science ®Google Scholar
• Planas E, Sánchez S, Rodriguez L, Pol O, Puig MM. Antinociceptive/anti-edema effects of liposomal morphine during acute inflammation of the rat paw. Pharmacology, 2000;60:121–7.
   PubMed Web of Science ®Google Scholar
• Puri A, Loomis K, Smith B, Lee J, Yavlovich A, Heldman E, Blumenthal R. Lipid-based nanoparticles as pharmaceutical drug carriers: From concepts to clinic. Crit Rev Ther Drug Carrier Syst, 2010;26:1–46.
   Google Scholar
• Rahman Z, Zidan AS, Khan MA. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur J Pharm Biopharm, 2010;76:127–37.
   PubMed Web of Science ®Google Scholar
• Rauck R, Bookbinder S, Bunker T, Alftine C, Negro-Vilar A,D, Jong E, Gershon S. (820): Once-a-day AVINZA vs. twice daily OxyContin® in an open-label extension (part II) to the ACTION trial for the treatment of chronic moderate-to-severe low back pain. J Pain, 2006;7:S56.
   Google Scholar
• Reisfield G, Bertholf R, Wilson G. Opiates and opioids: What a difference a name makes. J Opioid Manag, 2007;3:179–80.
   PubMedGoogle Scholar
• Risselada HJ, Marrink SJ. Curvature effects on lipid packing and dynamics in liposomes revealed by coarse grained molecular dynamics simulations. Phys Chem Chem Phys, 2009;11:2056–67.
   PubMed Web of Science ®Google Scholar
• Rosario-Meléndez R, Harris CL, Delgado-Rivera R, Yu L, Uhrich KE. PolyMorphine: An innovative biodegradable polymer drug for extended pain relief. J Control Release, 2012;162:538–44.
   PubMed Web of Science ®Google Scholar
• Russo P, Sacchetti C, Pasquali I, Bettini R, Massimo G, Colombo P, Rossi A. Primary microparticles and agglomerates of morphine for nasal insufflation. J Pharm Sci, 2006;95:2553–61.
   PubMed Web of Science ®Google Scholar
• Sailaja AK, Amareshwar P, Chakravarty P. Formulation of solid lipid nanoparticles and their applications. Curr Pharma Res, 2011;1:197–203.
   Google Scholar
• Sakakibara T, Wang Z, Paholpak P, Kosuwon W, Oo M, Kasai Y. A comparison of chronic pain prevalence in Japan, Thailand, and Myanmar. Pain Physician, 2013;16:603–8.
   PubMed Web of Science ®Google Scholar
• Sasaki J, Weil AJ, Ross EL, Nicholson BD. Effectiveness of polymer-coated extended-release morphine sulfate capsules in older patients with persistent moderate-to-severe pain: A subgroup analysis of a large, open-label, community-based trial. Curr Ther Res Clin Exp, 2007;68:137–50.
   PubMed Web of Science ®Google Scholar
• Sawicki W, Mazgalski J, Jakubowska I. Hot tabletting of slow-release tramadol hydrochloride microcapsules with cores obtained via compaction . Drug Dev Ind Pharm, 2010;36:209–17.
   PubMed Web of Science ®Google Scholar
• Schopflocher D, Taenzer P, Jovey R. The prevalence of chronic pain in Canada. Pain Res Manag, 2011;16:445–50.
   PubMed Web of Science ®Google Scholar
• Severino P, Andreani T, Macedo AS, Fangueiro JF, Santana MH, Silva AM, Souto EB. Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J Drug Deliv, 2012;2012:750891.
   PubMedGoogle Scholar
• Shaji J, Patole V. Protein and peptide drug delivery: Oral approaches. Indian J Pharm Sci, 2008;70:269–77.
   PubMed Web of Science ®Google Scholar
• Smith LJ, Krugner-Higby L, Clark M, Wendland A, Heath TD. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain. Comp Med, 2003;53:280–7.
   PubMed Web of Science ®Google Scholar
• Souto EB, Müller RH. 2010. Lipid nanoparticles: Effect on bioavailability and pharmacokinetic changes drug delivery. In: Hofmann FB, ed. Handbook of Experimental Pharmacology, Vol. 197. Berlin: Springer-Verlag, pp. 115–41.
   Google Scholar
• Sugar SL, Jr, LRH, Shannon P, Thomas LC, Nossaman BD. Comparison of extended-release epidural morphine with femoral nerve block to patient-controlled epidural analgesia for postoperative pain control of total knee arthroplasty: A case-controlled study. Ochsner J, 2011;11:17–21.
   PubMedGoogle Scholar
• Takechi C, Kawaguchi T, Kaneko F, Yamamuro O, Akita H, Ono M, Suzuki M. Incoherent quasielastic neutron scattering study on the polymorphism of tristearin: Dynamical properties of hydrocarbon chains. J Phys Chem B, 2007;111:9706–10.
   PubMed Web of Science ®Google Scholar
• Tracey I, Bushnell MC. How neuroimaging studies have challenged us to rethink: Is chronic pain a disease? J Pain, 2009;10:1113–20.
   PubMed Web of Science ®Google Scholar
• Trescot AM, Glaser SE, Hansen H, Benyamin R, Patel S, Manchikanti L. Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician, 2008a;11:S181–200.
   PubMed Web of Science ®Google Scholar
• Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician, 2008b;11:S133–53.
   PubMed Web of Science ®Google Scholar
• Van Den Kerkhof EG, Carley ME, Hopman WM, Ross-White A, Harrison MB. Prevalence of chronic pain and related risk factors in military veterans: A systematic review protocol. JBI Database Syst Rev Implement Rep, 2014;12:46–55.
   Google Scholar
• Vanterpool S, Coombs R, Fecho K. Continuous epidural infusion of morphine versus single epidural injection of extended-release morphine for postoperative pain control after arthroplasty: A retrospective analysis. Ther Clin Risk Manag, 2010;6:271–7.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Liu KS, Sung KC, Tsai CY, Fang JY. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Eur J Pharm Sci, 2009a;38:138–46.
   PubMed Web of Science ®Google Scholar
• Wang J-J, Liu K-S, Sung KC, Tsai C-Y, Fang J-Y. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: Lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles. J Microencapsul, 2009b;26:734–47.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Kaneko M, Maitani Y. Functional coating of liposomes using a folate-polymer conjugate to target folate receptors . Int J Nanomedicine, 2012;7:3679–88.
   PubMed Web of Science ®Google Scholar
• WHO. 2007. Normative guidelines on pain management – Report of a Delphi Study to determine the need for guidelines and to identify the number and topics of guidelines that should be developed by WHO. Geneva: World Health Organization.
   Google Scholar
• Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release, 2012;161:264–73.
   PubMed Web of Science ®Google Scholar
• Wood LD, Neumiller JJ, Carlson J, Setter SM, Corbett CF. Challenges of medication management in hospitalized patients with Parkinson's disease. . Am J Health Syst Pharm, 2010;67:2059–63.
   PubMed Web of Science ®Google Scholar
• Yaksh TL, Provencher JC, Rathbun ML, Kohn FR. Pharmacokinetics and efficacy of epidurally delivered sustained-release encapsulated morphine in dogs. Anesthesiology, 1999;90:1402–12.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao Y. Preparation and in vivo evaluation of thienorphine-loaded PLGA microspheres. Pharmazie, 2010;65:729–32.
   PubMed Web of Science ®Google Scholar
• Zhang Y-Z, Liao X-M, Yin G-F, Yuan P, Huang Z-B, Gu J-W, Yao Y-D, Chen X-C. Preparation of water soluble drugs-loaded microparticles using modified solution enhanced dispersion by supercritical CO2. Powder Technol, 2012;221:343–50.
   Web of Science ®Google Scholar
• Zhang Y, Chan HF, Leong KW. Advanced materials and processing for drug delivery: The past and the future. Adv Drug Deliv Rev, 2013;65:104–20.
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Ping QN, Xiao B. Microencapsulation and characterization of tramadol-resin complexes. J Control Release, 2000;66:107–13.
   PubMed Web of Science ®Google Scholar